Cargando…
Osteoporosis: the current status of mesenchymal stem cell-based therapy
Osteoporosis, or bone loss, is a progressive, systemic skeletal disease that affects millions of people worldwide. Osteoporosis is generally age related, and it is underdiagnosed because it remains asymptomatic for several years until the development of fractures that confine daily life activities,...
Autores principales: | Phetfong, Jitrada, Sanvoranart, Tanwarat, Nartprayut, Kuneerat, Nimsanor, Natakarn, Seenprachawong, Kanokwan, Prachayasittikul, Virapong, Supokawej, Aungkura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414670/ https://www.ncbi.nlm.nih.gov/pubmed/28536615 http://dx.doi.org/10.1186/s11658-016-0013-1 |
Ejemplares similares
-
Inhibitory effect of oxidative damage on cardiomyocyte differentiation from Wharton's jelly-derived mesenchymal stem cells
por: Nimsanor, Natakarn, et al.
Publicado: (2017) -
Computational identification of miRNAs that modulate the differentiation of mesenchymal stem cells to osteoblasts
por: Seenprachawong, Kanokwan, et al.
Publicado: (2016) -
Cardiogenic and Myogenic Gene Expression in Mesenchymal Stem Cells After 5-Azacytidine Treatment
por: Supokawej, Aungkura, et al.
Publicado: (2013) -
Bone marrow‐mesenchymal stem cell‐derived extracellular vesicles affect proliferation and apoptosis of leukemia cells in vitro
por: Phetfong, Jitrada, et al.
Publicado: (2021) -
Annexin A2 Improves the Osteogenic Differentiation of Mesenchymal Stem Cells Exposed to High-Glucose Conditions through Lessening the Senescence
por: Klabklai, Parin, et al.
Publicado: (2022)